Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies

INTRODUCTION: Methotrexate exhibits poor cutaneous bioavailability and systemic side effects on topical administration, so there is an unmet need for a novel carrier and its optimized therapy. Methotrexate-loaded nanostructured lipid carriers (MTXNLCs) were formulated and characterized to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Yogeeta O, Mahajan, Umesh B, Mahajan, Hitendra S, Ojha, Shreesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354956/
https://www.ncbi.nlm.nih.gov/pubmed/32753865
http://dx.doi.org/10.2147/IJN.S247007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354956/
https://www.ncbi.nlm.nih.gov/pubmed/32753865
http://dx.doi.org/10.2147/IJN.S247007

Ejemplares similares